CO99 Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Utilization Patterns for Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Among United States (US) Community Hematologists/Oncologists (CH/OS)
Abstract
Authors
B Feinberg A Klink T Schuler A Balanean, MPH. L McAllister D Liassou A Gajra D Porter